Literature DB >> 11091283

Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions.

L A Boven1, L Montagne, H S Nottet, C J De Groot.   

Abstract

MS is a demyelinating disease characterized by infiltration of monocytes and lymphocytes into the brain parenchyma, destruction of oligodendrocytes and loss of myelin. Since chemokines play a major role in the migration of monocytes and T cells, we here investigated the expression of the CC chemokines MIP-1alpha, MIP-1beta, and RANTES in brain tissue from MS patients using reverse transcriptase-polymerase chain reaction techniques. Both MIP-1beta as well as RANTES were found to be significantly elevated in brain tissue of MS patients. In addition, MIP-1alpha was also increased, although not significantly. Immunohistochemistry revealed that, whereas RANTES was mainly localized in reactive astrocytes, MIP-1alpha and MIP-1beta immunoreactivity was predominantly found in perivascular and parenchymal macrophages, containing myelin degradation products. Thus, chemokines appear to be associated with MS and an increased chemokine expression may further enhance disease progression by attracting more leucocytes into the brain parenchyma and by activation of effector functions of astrocytes and microglial cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11091283      PMCID: PMC1905780          DOI: 10.1046/j.1365-2249.2000.01334.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

Review 1.  Cellular aspects of HIV-1 infection of macrophages leading to neuronal dysfunction in in vitro models for HIV-1 encephalitis.

Authors:  H S Nottet; D R Bär; H van Hassel; J Verhoef; L A Boven
Journal:  J Leukoc Biol       Date:  1997-07       Impact factor: 4.962

2.  Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro.

Authors:  D D Taub; S M Turcovski-Corrales; M L Key; D L Longo; W J Murphy
Journal:  J Immunol       Date:  1996-03-15       Impact factor: 5.422

3.  Induction of RANTES expression by astrocytes and astrocytoma cell lines.

Authors:  D A Barnes; M Huston; R Holmes; E N Benveniste; V W Yong; P Scholz; H D Perez
Journal:  J Neuroimmunol       Date:  1996-12       Impact factor: 3.478

Review 4.  Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis.

Authors:  E N Benveniste
Journal:  J Mol Med (Berl)       Date:  1997-03       Impact factor: 4.599

5.  Cytokine expression in the brain during the acquired immunodeficiency syndrome.

Authors:  W R Tyor; J D Glass; J W Griffin; P S Becker; J C McArthur; L Bezman; D E Griffin
Journal:  Ann Neurol       Date:  1992-04       Impact factor: 10.422

Review 6.  Growth factors and myelin regeneration in multiple sclerosis.

Authors:  H D Webster
Journal:  Mult Scler       Date:  1997-04       Impact factor: 6.312

Review 7.  The immunopathology of chemotactic cytokines: the role of interleukin-8 and monocyte chemoattractant protein-1.

Authors:  R M Strieter; A E Koch; V B Antony; R B Fick; T J Standiford; S L Kunkel
Journal:  J Lab Clin Med       Date:  1994-02

Review 8.  Brain macrophages: neurotoxic or neurotrophic effector cells?

Authors:  M Mallat; B Chamak
Journal:  J Leukoc Biol       Date:  1994-09       Impact factor: 4.962

9.  Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody.

Authors:  M Takeya; T Yoshimura; E J Leonard; K Takahashi
Journal:  Hum Pathol       Date:  1993-05       Impact factor: 3.466

Review 10.  Protein growth factors as potential therapies for central nervous system demyelinative disorders.

Authors:  J B Grinspan; J Stern; B Franceschini; T Yasuda; D Pleasure
Journal:  Ann Neurol       Date:  1994       Impact factor: 10.422

View more
  27 in total

1.  Elevated expression of CCR5 by myeloid (CD11c+) blood dendritic cells in multiple sclerosis and acute optic neuritis.

Authors:  M Pashenkov; N Teleshova; M Kouwenhoven; V Kostulas; Y-M Huang; M Soderstrom; H Link
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

Review 2.  Chemokines and glial cells: a complex network in the central nervous system.

Authors:  Elena Ambrosini; Francesca Aloisi
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

Review 3.  Innate-adaptive crosstalk: how dendritic cells shape immune responses in the CNS.

Authors:  Benjamin D Clarkson; Erika Héninger; Melissa G Harris; JangEun Lee; Matyas Sandor; Zsuzsanna Fabry
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

4.  Haplotypes within genes of beta-chemokines in 17q11 are associated with multiple sclerosis: a second phase study.

Authors:  Tamara Vyshkina; Bernadette Kalman
Journal:  Hum Genet       Date:  2005-08-03       Impact factor: 4.132

5.  Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.

Authors:  R Pattarini; R J Smeyne; J I Morgan
Journal:  Neuroscience       Date:  2007-01-29       Impact factor: 3.590

Review 6.  Mechanisms of dendritic cell trafficking across the blood-brain barrier.

Authors:  Divya Sagar; Catherine Foss; Rasha El Baz; Martin G Pomper; Zafar K Khan; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-06       Impact factor: 4.147

7.  Plasmacytoid dendritic cells in multiple sclerosis: chemokine and chemokine receptor modulation by interferon-beta.

Authors:  Latt Latt Aung; Patricia Fitzgerald-Bocarsly; Suhayl Dhib-Jalbut; Konstantin Balashov
Journal:  J Neuroimmunol       Date:  2010-09-14       Impact factor: 3.478

Review 8.  CCR5 blockade for neuroinflammatory diseases--beyond control of HIV.

Authors:  Guillaume Martin-Blondel; David Brassat; Jan Bauer; Hans Lassmann; Roland S Liblau
Journal:  Nat Rev Neurol       Date:  2016-01-18       Impact factor: 42.937

Review 9.  Dendritic cells as therapeutic targets in neuroinflammation.

Authors:  Felix Luessi; Frauke Zipp; Esther Witsch
Journal:  Cell Mol Life Sci       Date:  2016-03-12       Impact factor: 9.261

10.  Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis.

Authors:  Anna Corcione; Simona Casazza; Elisa Ferretti; Debora Giunti; Emanuela Zappia; Angela Pistorio; Claudio Gambini; Giovanni Luigi Mancardi; Antonio Uccelli; Vito Pistoia
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.